CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 180 enrolled
Drug / intervention
Sodium Carboxymethylcellulose +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02028754
NCT02028754Phase 4Completed
CompareCT.gov

A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms

Allergan·interventional·Posted Jan 7, 2014·Updated Apr 23, 2014

In Brief

A Phase 4 clinical trial evaluating Sodium Carboxymethylcellulose, Levofloxacin, and 1 other intervention for Dry Eye Syndromes and Cataract. Completed, enrolled 180 participants across 1 site.

Detailed Summary

This study will evaluate the effect of sodium carboxymethylcellulose eye drops in the treatment of dry eye after cataract surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes, Cataract
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 7, 2014
Enrollment StartJul 1, 2011
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.5 years ago

Interventions

Sodium Carboxymethylcellulosedrug

Sodium carboxymethylcellulose (Refresh Liquigel®) 1 drop in the study eye 4 times a day for 30 days post-cataract surgery.

Levofloxacindrug

Levofloxacin 1 drop in the study eye 3 times a day for 7 days post-cataract surgery.

Prednisolonedrug

Prednisolone 1 drop in the study eye 4 times a day for the 1st week post surgery, 3 times a day for the 2nd week post surgery, 2 times a day for the 3rd week post surgery, and 1 time a day for the 4th week post surgery.